Program #891 • Available July 27, 2010
Certified for AMA PRA Category 1 Credit™ through July 27, 2013

Acute Pediatric Asthma: Therapeutic Evidence and Controversies

Faculty
Jill M. Baren, MD, MBE, FACEP, FAAP

Program Description

Asthma is one of the most common diseases of childhood, with a prevalence rate of 5.4%in the pediatric population, accounting for 17% of pediatric encounters in US emergency departments. Although there is no known cure for asthma, advances in scientific understanding of the disease's underlying mechanisms have produced treatment tools and management strategies that can improve the health of children with asthma. However, the variability in patient responses to asthma therapies makes a single treatment strategy particularly challenging. In this video, Dr. Jill Baren presents an evidence-based discussion about some of the controversies in the management of pediatric asthma, including the use of metered-dose inhalers versus nebulizers, levalbuterol versus albuterol, the role of ipratropium, and the use of inhaled corticosteroids in acute asthma. In addition, she reviews novel or uncommon therapeutic interventions, such as the use of bi-level positive airway pressure (BiPAP) and heliox therapy.

(30 minutes)

Method of Participation and Evaluation

To participate in this CME activity, please read the following information and click "Launch Program" at the bottom of this page. Complete the online evaluation at the conclusion of the activity. You may print your certificate immediately after completion of the evaluation. Please note: To view this program you need a computer with an Internet browser and audio and video capabilities.

Credit Information

Up to 0.5 AMA PRA Category 1 Credit

This activity is designed for pediatricians, primary care physicians, internists, emergency medicine physicians, hospitalists, and other healthcare professionals involved in the care of pediatric patients who present with asthma.

Learning Objectives

After taking part in this CME activity, participants should be able to:

  • Determine the correct treatment modality for the moderate to severe pediatric patient
  • Synthesize evidence for the use of bronchodilator, anticholinergic,and steroid therapy in children with acute asthma
  • Identify appropriate third-line treatment and airway management for pediatric patients who do not respond to standard therapy

Faculty Disclosures:

Jill M. Baren, MD, MBE, FACEP, FAAP

Jill M. Baren, MD, MBE, FACEP, FAAP, reports no such relationships to disclose.

The Foundation for Improving Patient Outcomes staff and the independent peer reviewer report no financial relationship with commercial interests.

CME Credit Designations

ACCME The Foundation for Improving Patient Outcomes (FFIPO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA FFIPO designates this educational activity for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AOA This activity is eligible for up to 0.5 hour of credit in Category 2-A of the American Osteopathic Association.


Launch Program
Web Evaluation
Print Evaluation
«
Please login or create an account to access course. For more information, click here.